Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Reviews in Allergy & Immunology
Published in: Clinical Reviews in Allergy & Immunology 2/2016

01-04-2016

Medical Complications of Tattoos: A Comprehensive Review

Authors: Parvez S. Islam, Christopher Chang, Carlo Selmi, Elena Generali, Arthur Huntley, Suzanne S. Teuber, M. Eric Gershwin

Published in: Clinical Reviews in Allergy & Immunology | Issue 2/2016

Login to get access

Abstract

Tattoos are defined as the introduction of exogenous pigments into the dermis in order to produce a permanent design. This process may occur unintentional or may be deliberately administered for cosmetic or medical reasons. Tattoos have been around for over 5000 years and over time have evolved to represent a common cosmetic practice worldwide. Currently, adverse reactions are relatively rare and generally unpredictable and predominantly include immune-mediated reactions and skin infections. Along with better healthcare standards and more stringent public health mandates such as the provision of disposable needles, major infectious complications related to hepatitis and human retroviral infections have decreased significantly. When they do occur, skin infections are most frequently associated with Staphylococcus aureus or Streptococcus pyogenes. The aim of this study is to review the types and rates of medical complications of permanent tattoos. PubMed search and search dates were open ended. Acute local inflammation is the most common complication, but infections, allergic contact dermatitis, and other inflammatory or immune responses that are not well-characterized may occur. As many patients with immune reactions to tattoos do not react on skin or patch testing, it is postulated that the antigens contained in dyes or pigments are such small molecules that they need to be haptenized in order to become immunogenic. Red ink is associated more frequently with long-term reactions, including granulomatous and pseudolymphomatous phenomena or morphea-like lesions and vasculitis. Exacerbation of preexisting psoriasis, atopic dermatitis, and pyoderma gangrenosum may occur after tattooing. There is no well-defined association between cancer and tattoos. The treatment of tattoo-related complications may include local destructive measures (cryotherapy, electro-surgery, dermabrasion, chemical destruction, ablative laser destruction), surgical excision, and thermolysis of the pigment using Q-switched laser therapy.
Literature
1.
Sperry K (1991) Tattoos and tattooing. Part I: history and methodology. Am J Forensic Med Pathol 12:313–319CrossRefPubMed
2.
3.
Wenzel SM, Welzel J, Hafner C, Landthaler M, Baumler W (2010) Permanent make-up colorants may cause severe skin reactions. Contact Dermatitis 63:223–227CrossRefPubMed
4.
Kierstein L, Kjelskau KC (2015) Tattoo as art, the drivers behind the fascination and the decision to become tattooed. Curr Probl Dermatol 48:37–40CrossRefPubMed
5.
Kean WF, Tocchio S, Kean M, Rainsford KD (2013) The musculoskeletal abnormalities of the Similaun Iceman (“OTZI”): clues to chronic pain and possible treatments. Inflammopharmacology 21:11–20CrossRefPubMedPubMedCentral
6.
7.
Laumann AE, Derick AJ (2006) Tattoos and body piercings in the United States: a national data set. J Am Acad Dermatol 55:413–421CrossRefPubMed
8.
Cegolon L, Mastrangelo G, Mazzoleni F et al (2010) Body art in 4,277 Italian secondary school adolescents: prevalence and associations with personal and family characteristics. Fam Med 42:273–279PubMed
9.
Laux P, Tralau T, Tentschert J et al (2015) A medical-toxicological view of tattooing. Lancet 387(10016):395-402
10.
Klugl I, Hiller KA, Landthaler M, Baumler W (2010) Incidence of health problems associated with tattooed skin: a nation-wide survey in German-speaking countries. Dermatology 221:43–50CrossRefPubMed
11.
Simunovic C, Shinohara MM (2014) Complications of decorative tattoos: recognition and management. Am J Clin Dermatol 15:525–536CrossRefPubMed
12.
Korner R, Pfohler C, Vogt T, Muller CS (2013) Histopathology of body art revisited - analysis and discussion of 19 cases. J Dtsch Dermatol Ges 11:1073–1080PubMed
13.
Mayers LB, Judelson DA, Moriarty BW, Rundell KW (2002) Prevalence of body art (body piercing and tattooing) in university undergraduates and incidence of medical complications. Mayo Clin Proc 77:29–34CrossRefPubMed
14.
Forbes GB (2001) College students with tattoos and piercings: motives, family experiences, personality factors, and perception by others. Psychol Rep 89:774–786CrossRefPubMed
15.
LeBlanc PM, Hollinger KA, Klontz KC (2012) Tattoo ink-related infections—awareness, diagnosis, reporting, and prevention. N Engl J Med 367:985–987CrossRefPubMed
16.
Beute TC, Miller CH, Timko AL, Ross EV (2008) In vitro spectral analysis of tattoo pigments. Dermatol Surg 34:508–515, discussion 515–506PubMed
17.
Forte G, Petrucci F, Cristaudo A, Bocca B (2009) Market survey on toxic metals contained in tattoo inks. Sci Total Environ 407:5997–6002CrossRefPubMed
18.
Maeda N (1964) Histologic study of the tattoo mark. Dermatol Trop Ecol Geogr 18:207–216PubMed
19.
Lea PJ, Pawlowski A (1987) Human tattoo. Electron microscopic assessment of epidermis, epidermal-dermal junction, and dermis. Int J Dermatol 26:453–458CrossRefPubMed
20.
Fujita H, Nishii Y, Yamashita K, Kawamata S, Yoshikawa K (1988) The uptake and long-term storage of India ink particles and latex beads by fibroblasts in the dermis and subcutis of mice, with special regard to the non-inflammatory defense reaction by fibroblasts. Arch Histol Cytol 51:285–294CrossRefPubMed
21.
Liszewski W, Kream E, Helland S, Cavigli A, Lavin BC, Murina A (2015) The demographics and rates of tattoo complications, regret, and unsafe tattooing practices: a cross-sectional study. Dermatol Surg 41:1283–1289CrossRefPubMed
22.
Nishioka S, Gyorkos TW (2001) Tattoos as risk factors for transfusion-transmitted diseases. Int J Infect Dis 5:27–34CrossRefPubMed
23.
24.
Kluger N (2009) Bacterial endocarditis and body art: suggestions for an active prevention. Int J Cardiol 136:112–113CrossRefPubMed
25.
Kluger N (2012) Acute complications of tattooing presenting in the ED. Am J Emerg Med 30:2055–2063CrossRefPubMed
26.
Conaglen PD, Laurenson IF, Sergeant A, Thorn SN, Rayner A, Stevenson J (2013) Systematic review of tattoo-associated skin infection with rapidly growing mycobacteria and public health investigation of a cluster in Scotland, 2010. Euro Surveill 18:20553
27.
Falsey RR, Kinzer MH, Hurst S et al (2013) Cutaneous inoculation of nontuberculous mycobacteria during professional tattooing: a case series and epidemiologic study. Clin Infect Dis 57:e143–e147CrossRefPubMed
28.
Sergeant A, Conaglen P, Laurenson IF et al (2013) Mycobacterium chelonae infection: a complication of tattooing. Clin Exp Dermatol 38:140–142CrossRefPubMed
29.
Mittal RR, Singla A, Gupta R (2002) Inoculation leprosy after tattooing. Indian Journal of Dermatology, Venereology and Leprology. 68:116
30.
Singh G, Tutakne MA, Tiwari VD, Dutta RK (1985) Inoculation leprosy developing after tattooing—a case report. Indian J Lepr 57:887–888PubMed
31.
Cowan RK, Martens MG (1993) Toxic shock syndrome mimicking pelvic inflammatory disease presumably resulting from tattoo. South Med J 86:1427–1431CrossRefPubMed
32.
Chowfin A, Potti A, Paul A, Carson P (1999) Spinal epidural abscess after tattooing. Clin Infect Dis 29:225–226CrossRefPubMed
33.
34.
Tse D, Khan S, Clarke S (2009) Bacterial endocarditis complicating body art. Int J Cardiol 133:e28–e29CrossRefPubMed
35.
Korman TM, Grayson ML, Turnidge JD (1997) Polymicrobial septicaemia with Pseudomonas aeruginosa and Streptococcus pyogenes following traditional tattooing. J Infect 35:203CrossRefPubMed
36.
Kluger N, Saarinen K (2014) Aspergillus fumigatus infection on a home-made tattoo. Br J Dermatol 170:1373–1375CrossRefPubMed
37.
Wanat KA, Tyring S, Rady P, Kovarik CL (2014) Human papillomavirus type 27 associated with multiple verruca within a tattoo: report of a case and review of the literature. Int J Dermatol 53:882–884CrossRefPubMed
38.
Lee-Wong M, Karagic M, Silverberg N (2009) Anaphylactic reaction to permanent tattoo ink. Ann Allergy Asthma Immunol 103:88–89CrossRefPubMed
39.
Clark RA, Chong B, Mirchandani N et al (2006) The vast majority of CLA+ T cells are resident in normal skin. J Immunol 176:4431–4439CrossRefPubMed
40.
41.
Brady BG, Gold H, Leger EA, Leger MC (2015) Self-reported adverse tattoo reactions: a New York City Central Park study. Contact Dermatitis 73:91–99CrossRefPubMed
42.
Thum CK, Biswas A (2015) Inflammatory complications related to tattooing: a histopathological approach based on pattern analysis. Am J Dermatopathol 37:54–66CrossRefPubMed
43.
Winkelmann RK, Harris RB (1979) Lichenoid delayed hypersensitivity reactions in tattoos. J Cutan Pathol 6:59–65CrossRefPubMed
44.
Garcovich S, Carbone T, Avitabile S, Nasorri F, Fucci N, Cavani A (2012) Lichenoid red tattoo reaction: histological and immunological perspectives. Eur J Dermatol 22:93–96PubMed
45.
Anolik R, Mandal R, Franks AG Jr (2010) Sarcoidal tattoo granuloma. Dermatol Online J 16:19PubMed
46.
Madan NK, Vallonthaiel AG, Arava S, Ali MF, Goyal M, Singh MK (2015) Perforating granuloma annulare in a young male following application of the tattoo. Ind Dermatol Online J 6:296–298CrossRef
47.
Wood A, Hamilton SA, Wallace WA, Biswas A (2014) Necrobiotic granulomatous tattoo reaction: report of an unusual case showing features of both necrobiosis lipoidica and granuloma annulare patterns. Am J Dermatopathol 36:e152–e155CrossRefPubMed
48.
Gaudron S, Ferrier-Le Bouedec MC, Franck F, D’Incan M (2015) Azo pigments and quinacridones induce delayed hypersensitivity in red tattoos. Contact Dermatitis 72:97–105CrossRefPubMed
49.
50.
Bernstein EF (2015) A widespread allergic reaction to black tattoo ink caused by laser treatment. Lasers Surg Med 47:180–182CrossRefPubMed
51.
Jacob SE, Castanedo-Tardan MP, Blyumin ML (2008) Inflammation in green (chromium) tattoos during patch testing. Dermatitis 19:E33–E34PubMed
52.
Yoong C, Vun YY, Spelman L, Muir J (2010) True blue football fan: tattoo reaction confined to blue pigment. Australas J Dermatol 51:21–22CrossRefPubMed
53.
54.
55.
Hessert MJ, Devlin J (2011) Ink sick: tattoo ink hypersensitivity vasculitis. Am J Emerg Med 29:1237.e1233–1234
56.
Serup J, Hutton Carlsen K (2014) Patch test study of 90 patients with tattoo reactions: negative outcome of allergy patch test to baseline batteries and culprit inks suggests allergen(s) are generated in the skin through haptenization. Contact Dermatitis 71:255–263CrossRefPubMed
57.
Hutton Carlsen K, Serup J (2014) Photosensitivity and photodynamic events in black, red and blue tattoos are common: a ‘Beach Study’. J Eur Acad Dermatol Venereol 28:231–237CrossRefPubMed
58.
Bassi A, Campolmi P, Cannarozzo G et al (2014) Tattoo-associated skin reaction: the importance of an early diagnosis and proper treatment. Biomed Res Int 2014:354608
59.
Kaplan DH, Igyarto BZ, Gaspari AA (2012) Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12:114–124PubMedPubMedCentral
60.
Aptula AO, Roberts DW, Pease CK (2007) Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles. Contact Dermatitis 56:54–56CrossRefPubMed
61.
Kaur RR, Kirby W, Maibach H (2009) Cutaneous allergic reactions to tattoo ink. J Cosmet Dermatol 8:295–300CrossRefPubMed
62.
Cruz FA, Lage D, Frigerio RM, Zaniboni MC, Arruda LH (2010) Reactions to the different pigments in tattoos: a report of two cases. An Bras Dermatol 85:708–711CrossRefPubMed
63.
Huynh TN, Jackson JD, Brodell RT (2014) Tattoo and vaccination sites: possible nest for opportunistic infections, tumors, and dysimmune reactions. Clin Dermatol 32:678–684CrossRefPubMed
64.
Antony FC, Harland CC (2003) Red ink tattoo reactions: successful treatment with the Q-switched 532 nm Nd:YAG laser. Br J Dermatol 149:94–98CrossRefPubMed
65.
Kluger N (2013) Sarcoidosis on tattoos: a review of the literature from 1939 to 2011. Sarcoidosis Vasc Diffuse Lung Dis 30:86–102PubMed
66.
Shinohara MM, Nguyen J, Gardner J, Rosenbach M, Elenitsas R (2012) The histopathologic spectrum of decorative tattoo complications. J Cutan Pathol 39:1110–1118CrossRefPubMed
67.
68.
Marchesi A, Parodi PC, Brioschi M et al (2014) Tattoo ink-related cutaneous pseudolymphoma: a rare but significant complication. Case report and review of the literature. Aesthetic Plast Surg 38:471–478CrossRefPubMed
69.
Kluger N, Vermeulen C, Moguelet P et al (2010) Cutaneous lymphoid hyperplasia (pseudolymphoma) in tattoos: a case series of seven patients. J Eur Acad Dermatol Venereol 24:208–213CrossRefPubMed
70.
Kluger N, Phan A, Debarbieux S, Balme B, Thomas L (2008) Skin cancers arising in tattoos: coincidental or not? Dermatology 217:219–221CrossRefPubMed
71.
Kluger N, Minier-Thoumin C, Plantier F (2008) Keratoacanthoma occurring within the red dye of a tattoo. J Cutan Pathol 35:504–507CrossRefPubMed
72.
Kluger N, Mathelier-Fusade P, Moguelet P (2009) Scleroderma-like reaction restricted to the red parts of a tattoo. Acta Derm Venereol 89:95–96CrossRefPubMed
73.
Lobato-Berezo A, Churruca-Grijelmo M, Martinez-Perez M et al (2014) Dermatofibroma arising within a black tattoo. Case Rep Dermatol Med 2014:745304
74.
Bittencourt Mde J, Miranda MF, Parijos AM, Mesquita LB, Fonseca DM, Jambo DA (2013) Dermatofibroma in a black tattoo: report of a case. An Bras Dermatol 88:614–616CrossRefPubMed
75.
Reddy KK, Hanke CW, Tierney EP (2011) Malignancy arising within cutaneous tattoos: case of dermatofibrosarcoma protuberans and review of literature. J Drugs Dermatol 10:837–842PubMed
76.
77.
Ghorpade A (2015) Tattoo-induced psoriasis. Int J Dermatol 54:1180–11822
78.
79.
Tendas A, Niscola P, Barbati R et al (2011) Tattoo related pyoderma/ectyma gangrenous as presenting feature of relapsed acute myeloid leukaemia: an exceptionally rare observation. Injury 42:546–547CrossRefPubMed
80.
Jacobson S, Martin DB, Deng A, Cooper JZ (2008) Pyoderma gangrenosum following tattoo placement in a patient with acute myelogenous leukemia. J Dermatolog Treat 19:58–60CrossRefPubMed
81.
Deeken A, Jefferson J, Hawkinson D, Fraga GR (2014) Localized chronic fibrosing vasculitis in a tattoo: a unique adverse tattoo reaction. Am J Dermatopathol 36:e81–e83CrossRefPubMed
82.
Guy GP Jr, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC (2015) Vital signs: melanoma incidence and mortality trends and projections—United States, 1982–2030. MMWR Morb Mortal Wkly Rep 64:591–596PubMed
83.
Rogers HW, Weinstock MA, Feldman SR, Coldiron BM (2015) Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012. JAMA Dermatol 151:1081–1086CrossRefPubMed
84.
Birnie AJ, Kulkarni K, Varma S (2006) Basal cell carcinoma arising in a tattoo. Clin Exp Dermatol 31:820–821CrossRefPubMed
85.
Souza ES, Rocha Bde O, Batista Eda S, Oliveira RF, Farre L, Bittencourt AL (2014) T-cell-predominant lymphoid hyperplasia in a tattoo. An Bras Dermatol 89:1019–1021CrossRefPubMedPubMedCentral
86.
Sweeney SA, Hicks LD, Ranallo N, Snyder N t, Soldano AC (2013) Perforating granulomatous dermatitis reaction to exogenous tattoo pigment: a case report and review of the literature. Am J Dermatopathol 35:754–756CrossRefPubMed
87.
Luebberding S, Alexiades-Armenakas M (2014) New tattoo approaches in dermatology. Dermatol Clin 32:91–96CrossRefPubMed
88.
England RW, Vogel P, Hagan L (2002) Immediate cutaneous hypersensitivity after treatment of tattoo with Nd:YAG laser: a case report and review of the literature. Ann Allergy Asthma Immunol 89:215–217CrossRefPubMed
89.
Sperry K (1992) Tattoos and tattooing. Part II: gross pathology, histopathology, medical complications, and applications. Am J Forensic Med Pathol 13:7–17CrossRefPubMed
90.
Ho DD, London R, Zimmerman GB, Young DA (2002) Laser-tattoo removal—a study of the mechanism and the optimal treatment strategy via computer simulations. Lasers Surg Med 30:389–397CrossRefPubMed
91.
Weiss ET, Geronemus RG (2011) Combining fractional resurfacing and Q-switched ruby laser for tattoo removal. Dermatol Surg 37:97–99CrossRefPubMed
92.
93.
Douglas MJ, Swenerton JE (2002) Epidural anesthesia in three parturients with lumbar tattoos: a review of possible implications. Can J Anaesth 49:1057–1060CrossRefPubMed
94.
Ferraz IL, Barros GA, Ferreira Neto PG et al (2015) Does spinal block through tattooed skin cause histological changes in nervous tissue and meninges?: an experimental model in rabbits. Reg Anesth Pain Med 40:533–538CrossRefPubMed
95.
Serup J (2015) Seamless prevention of adverse events from tattooing: integrated strategy emphasising the customer-tattooist interaction. Curr Probl Dermatol 48:236–247CrossRefPubMed
Metadata
Title
Medical Complications of Tattoos: A Comprehensive Review
Authors
Parvez S. Islam
Christopher Chang
Carlo Selmi
Elena Generali
Arthur Huntley
Suzanne S. Teuber
M. Eric Gershwin
Publication date
01-04-2016
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 2/2016
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-016-8532-0

Other articles of this Issue 2/2016

Clinical Reviews in Allergy & Immunology 2/2016 Go to the issue

ReviewPaper

Hypereosinophilic Syndrome

ReviewPaper

Eosinophilic Skin Diseases: A Comprehensive Review

ReviewPaper

Eosinophilic Gastroenteritis and Colitis: a Comprehensive Review

ReviewPaper

The Eosinophil in Health and Disease: from Bench to Bedside and Back

ReviewPaper

The Eosinophil in Infection

ReviewPaper

Biological Modulators in Eosinophilic Diseases
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits